SNYDER DAVID S (Chief Financial Officer) purchased 25.7% of their position (1.80K shares) of COYA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $12.9K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/14/2024ACC: 0001493152-24-046106
Officer· Chief Financial Officer
Since Dec 2022
+1.80K
Net shares
Net buyer
$12.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1.80K acquired
Non-Derivative Transactions1
Common Stock, par value $0.0001 per share
Direct
Shares
+1.80K
Price / share
$7.19
Trade value
$12.93K
% of position
25.7%
11/14/2024
7K→8.80K
Total
Net shares
+1.80K
Net value
$12.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share Direct | 11/14/2024 | P · Purchase | +1.80K | $7.19 | $12.93K | 25.7% | 7K | 8.80K |
| Total | +1.80K | $12.93K | ||||||
Derivative Transactions0
No derivative transactions reported